Cargando…

Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell

Protein arginine methyltransferase 1 (PRMT1) can catalyze the protein arginine methylation by transferring the methyl group from S-adenosyl-L-methionine (SAM) to the guanidyl nitrogen atom of protein arginine, which influences a variety of biological processes including epithelial–mesenchymal transi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Caijiao, Dong, Luyao, Zhao, Ziqi, Zhang, Zeqing, Sun, Yutong, Li, Chonglong, Li, Guoqing, You, Xuefu, Yang, Xinyi, Wang, Hao, Hong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214036/
https://www.ncbi.nlm.nih.gov/pubmed/35755248
http://dx.doi.org/10.3389/fchem.2022.888727
_version_ 1784730936246534144
author Wang, Caijiao
Dong, Luyao
Zhao, Ziqi
Zhang, Zeqing
Sun, Yutong
Li, Chonglong
Li, Guoqing
You, Xuefu
Yang, Xinyi
Wang, Hao
Hong, Wei
author_facet Wang, Caijiao
Dong, Luyao
Zhao, Ziqi
Zhang, Zeqing
Sun, Yutong
Li, Chonglong
Li, Guoqing
You, Xuefu
Yang, Xinyi
Wang, Hao
Hong, Wei
author_sort Wang, Caijiao
collection PubMed
description Protein arginine methyltransferase 1 (PRMT1) can catalyze the protein arginine methylation by transferring the methyl group from S-adenosyl-L-methionine (SAM) to the guanidyl nitrogen atom of protein arginine, which influences a variety of biological processes including epithelial–mesenchymal transition (EMT) and EMT-mediated mobility of cancer cells. The upregulation of PRMT1 is involved in a diverse range of cancer, such as lung cancer, and there is an urgent need to develop novel and potent PRMT1 inhibitors. In this article, a series of 2,5-substituted furan derivatives and 2,4-substituted thiazole derivatives were designed and synthesized by targeting at the substrate arginine-binding site on PRMT1, and 10 compounds demonstrated significant inhibitory effects against PRMT1. Among them, the most potent inhibitor, compound 1r (WCJ-394), significantly affected the expression of PRMT1-related proteins in A549 cells and downregulated the expression of mesenchymal markers, by which WCJ-394 inhibited the TGF-β1-induced EMT in A549 cells and prevented the cancer cell migration. The current study demonstrated that WCJ-394 was a potent PRMT1 inhibitor, which could be used as the leading compound for further drug discovery.
format Online
Article
Text
id pubmed-9214036
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92140362022-06-23 Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell Wang, Caijiao Dong, Luyao Zhao, Ziqi Zhang, Zeqing Sun, Yutong Li, Chonglong Li, Guoqing You, Xuefu Yang, Xinyi Wang, Hao Hong, Wei Front Chem Chemistry Protein arginine methyltransferase 1 (PRMT1) can catalyze the protein arginine methylation by transferring the methyl group from S-adenosyl-L-methionine (SAM) to the guanidyl nitrogen atom of protein arginine, which influences a variety of biological processes including epithelial–mesenchymal transition (EMT) and EMT-mediated mobility of cancer cells. The upregulation of PRMT1 is involved in a diverse range of cancer, such as lung cancer, and there is an urgent need to develop novel and potent PRMT1 inhibitors. In this article, a series of 2,5-substituted furan derivatives and 2,4-substituted thiazole derivatives were designed and synthesized by targeting at the substrate arginine-binding site on PRMT1, and 10 compounds demonstrated significant inhibitory effects against PRMT1. Among them, the most potent inhibitor, compound 1r (WCJ-394), significantly affected the expression of PRMT1-related proteins in A549 cells and downregulated the expression of mesenchymal markers, by which WCJ-394 inhibited the TGF-β1-induced EMT in A549 cells and prevented the cancer cell migration. The current study demonstrated that WCJ-394 was a potent PRMT1 inhibitor, which could be used as the leading compound for further drug discovery. Frontiers Media S.A. 2022-06-08 /pmc/articles/PMC9214036/ /pubmed/35755248 http://dx.doi.org/10.3389/fchem.2022.888727 Text en Copyright © 2022 Wang, Dong, Zhao, Zhang, Sun, Li, Li, You, Yang, Wang and Hong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Wang, Caijiao
Dong, Luyao
Zhao, Ziqi
Zhang, Zeqing
Sun, Yutong
Li, Chonglong
Li, Guoqing
You, Xuefu
Yang, Xinyi
Wang, Hao
Hong, Wei
Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell
title Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell
title_full Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell
title_fullStr Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell
title_full_unstemmed Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell
title_short Design and Synthesis of Novel PRMT1 Inhibitors and Investigation of Their Effects on the Migration of Cancer Cell
title_sort design and synthesis of novel prmt1 inhibitors and investigation of their effects on the migration of cancer cell
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214036/
https://www.ncbi.nlm.nih.gov/pubmed/35755248
http://dx.doi.org/10.3389/fchem.2022.888727
work_keys_str_mv AT wangcaijiao designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT dongluyao designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT zhaoziqi designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT zhangzeqing designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT sunyutong designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT lichonglong designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT liguoqing designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT youxuefu designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT yangxinyi designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT wanghao designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell
AT hongwei designandsynthesisofnovelprmt1inhibitorsandinvestigationoftheireffectsonthemigrationofcancercell